Related Experiment Video
Updated: Sep 7, 2025

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin
Published on: March 24, 2023
SHANK3 deficiency leads to myelin defects in the central and peripheral nervous system
Mariagiovanna Malara1,2, Anne-Kathrin Lutz1, Berra Incearap1,2
1Institute for Anatomy and Cell Biology, Ulm University, Albert-Einstein Allee 11, 89081, Ulm, Germany.
Abstract:
Mutations or deletions of the SHANK3 gene are causative for Phelan-McDermid syndrome (PMDS), a syndromic form of autism spectrum disorders (ASDs). We analyzed Shank3Δ11(-/-) mice and organoids from PMDS individuals to study effects on myelin. SHANK3 was found to be expressed in oligodendrocytes and Schwann cells, and MRI analysis of Shank3Δ11(-/-) mice revealed a reduced volume of the corpus callosum as seen in PMDS patients. Myelin proteins including myelin basic protein showed significant temporal and regional differences with lower levels in the CNS but increased amounts in the PNS of Shank3Δ11(-/-) animals. Node, as well as paranode, lengths were increased and ultrastructural analysis revealed region-specific alterations of the myelin sheaths. In PMDS hiPSC-derived cerebral organoids we observed an altered number and delayed maturation of myelinating cells. These findings provide evidence that, in addition to a synaptic deregulation, impairment of myelin might profoundly contribute to the clinical manifestation of SHANK3 deficiency.
Insights
SHANK3 gene mutations cause Phelan-McDermid syndrome (PMDS), impacting brain myelin. This study reveals myelin deficits in PMDS models, suggesting a key role in the disorder’s symptoms.
Area of Science:
- Neuroscience
- Genetics
- Developmental Biology
Background:
- SHANK3 gene mutations are linked to Phelan-McDermid syndrome (PMDS), a condition associated with autism spectrum disorders (ASDs).
- Previous research has primarily focused on synaptic dysfunction in PMDS.
Purpose of the Study:
- To investigate the role of SHANK3 in myelin formation and maintenance.
- To explore the impact of SHANK3 deficiency on the central nervous system (CNS) and peripheral nervous system (PNS) myelin.
Main Methods:
- Analysis of Shank3Δ11(-/-) mice and induced pluripotent stem cell (iPSC)-derived cerebral organoids from PMDS individuals.
- Magnetic Resonance Imaging (MRI) to assess brain structure.
- Western blotting to quantify myelin protein levels.
- Electron microscopy for ultrastructural analysis of myelin sheaths.
Main Results:
- SHANK3 is expressed in myelinating cells (oligodendrocytes and Schwann cells).
- Shank3Δ11(-/-) mice exhibited reduced corpus callosum volume, altered myelin protein levels (decreased in CNS, increased in PNS), and changes in node/paranode lengths.
- PMDS organoids showed delayed maturation and altered numbers of myelinating cells.
Conclusions:
- SHANK3 deficiency significantly impairs myelin development and integrity in both the CNS and PNS.
- Myelin dysfunction is a key pathological feature of PMDS, contributing to the syndrome's clinical manifestations alongside synaptic deregulation.
More Related Videos
04:02Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
Published on: November 29, 2024
08:57Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
Related Concept Videos
Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Neurogenesis and Regeneration of Nervous Tissue
Neurulation
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...